findmyKOL
Clinical trialNCT02722512TerminatedPhase 1Interventional

Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine

SponsorAnn & Robert H Lurie Children's Hospital of ChicagoEnrollment10Anaplastic EpendymomaAstrocytoma, Grade IIIClear Cell EpendymomaEpendymomaGlioblastoma Multiforme
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine whether Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine is an feasible and safe treatment for pediatric patients with newly-diagnosed High-Grade Gliomas or recurrent, resectable High-Grade Gliomas and Ependymomas.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Stewart Goldman, MD

    Ann & Robert H Lurie Children's Hospital of Chicago

    Principal Investigator
    clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Ann & Robert H. Lurie Children'S Hospital of Chicago

    Chicago, Illinois, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Heat Shock Protein Peptide Complex-96
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jul 2016
Primary completion
13 Nov 2019
Completion
13 Nov 2019
Last update posted
18 Feb 2025
Registered enrollment
10
Registry id
NCT02722512
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.